PFSA - Profusa, Inc. Common Stock Stock Analysis

Stock Taper

OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS

PFSA

PROFUSA, INC. COMMON STOCK

NASDAQ

$1.75

▲ UP 3.55% (0.06)

KEY STATISTICS

Market Cap$1.93 M

52w High$3000.00

52w Low$1.58

Dividend Yield—

Frequency—

P/E-0.02

Volume270.51K

Shares Out.1.10M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Jack E. Stover

ABOUT

SECTOR

Healthcare

WENT PUBLIC

July 14, 2025

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

SPLIT RECORD

DATE	TYPE	RATIO
2026-08-17	Reverse	1:4
2026-07-07	Reverse	1:25
2026-02-09	Reverse	1:75

ETFS HOLDING THIS STOCK

ETFS HOLDING

LISTED HERE

RANKED BY POSITION SIZE

VXF

0.00%

INSTITUTIONAL OWNERSHIP

SHARES OWNED

5.96%

HOLDERS

TOP 7 OF 7 · RANKED BY POSITION SIZE

Citadel Advisors LLC

30.8K sh

$15.64K

Geode Capital Management, LLC

30.7K sh

$15.57K

Tower Research Capital LLC (Trc)

Sbi Securities Co., Ltd.

PRICE

$1.75 ▲ UP 3.55% (+$0.06)

OVERLAYS

About Profusa, Inc. Common Stock

https://profusa.com ↗

A digital health company creating tissue-integrating biosensors like Lumee™ Oxygen to continuously monitor body chemistry and deliver AI-driven insights for managing chronic conditions such as diabetes and critical limb ischemia.

INDUSTRY

Medical - Devices

A PRODUCT PROFUSA, INC. COMMON STOCK IS KNOWN FOR

Lumee™ tissue oxygen monitoring system

The Lumee™ tissue oxygen monitoring system is a digital health device with a biosensor for continuous, real-time tissue oxygen measurement, recently launched for healthcare research and used to monitor conditions like Chronic Limb Threatening Isch...

COMPETITORS

COMPETITOR

Profusa, Inc. Common Stock in 2025

SENTIMENT: + POSITIVE

RESTRUCTURING · DECEMBER 2025

Profusa Stock Skyrockets Over 130% After Announcing Debt Restructuring to Reduce Dilution

Profusa announced a significant restructuring of its Senior Secured Convertible Notes, which included raising the conversion floor price from $0.10 to $0.35. This move was aimed at reducing potential shareholder dilution and providing greater financial flexibility, leading to a massive surge in the company's stock price and extremely high trading volume.

CAPITAL ALLOCATION · DECEMBER 2025 · COMPLETED

Profusa Restructures Senior Secured Convertible Notes to Reduce Shareholder Dilution and Enhance Financial Flexibility Ahead of Commercial Launch

In a pivotal financial restructuring, Profusa amended its Senior Secured Convertible Notes, significantly increasing the conversion floor price from $0.10 to $0.35. This move was designed to lessen potential shareholder dilution and provide greater flexibility for note repayment as the company prepares for its 2026 commercial launch.